Skip to main content

Table 1 Clinicopathological characteristics of 80 invasive breast cancer patients

From: High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer

Characteristic Long- term survivors ≥8 years Short-term survivors <8 years
No. of patients (%)
Mean age (years) 55 (27–73) 51 (33–72)
Histologic type   
Invasive ductal 33 (82.5) 31 (77.5)
Invasive lobular 3 (7.5) 7 (17.5)
Invasive ductal + lobular 0 (0) 1 (2.5)
Other 3 (7.5) 1 (2.5)
Not available 1 (2.5) 0 (0)
Pathologic tumor size (mm)   
pT1 (0–20) 8 (20) 8 (20)
pT2 (>20-50) 27 (67.5) 29 (72.5)
pT3 (>50) 5 (12.5) 3 (7.5)
BRE grade   
I-II 21 (100) 20 (100)
III 19 (100) 20 (100)
No. of axillary lymph nodes   
0 14 (35) 14 (35)
1-3 12 (30) 12 (30)
≥4 14 (35) 14 (35)
ER/PR receptor   
Negative 19 (47.5) 20 (50)
Positive 20 (50) 20 (50)
Not available 1 (2.5) 0 (0)
HER2 status   
Positive 15 (37.5) 11 (27.5)
Negative 21 (52.5) 20 (50)
Not available 4 (10) 9 (22.5)
Surgery   
Lumpectomy 15 (37.5) 15 (37.5)
Mastectomy 25 (62.5) 25 (62.5)
Radiotherapy   
No 19 (86) 19 (47.5)
Yes 11 (20) 20 (50)
Not available 2 (9) 1 (2.5)
Chemotherapy   
No 12 (36.5) 16 (41)
Yes 17 (51.5) 23 (59)
Not available 4 (12) 0 (0)
Endocrine therapy   
No 15 (45.5) 20 (51)
Yes 13 (39.5) 18 (46)
Not available 5 (15) 1 (3)
Recurrence   
No 15 (45) 10 (25)
Yes 3 (10) 15 (37.5)
Not available 15 (45) 15 (37.5)
  1. BRE, Bloom, Richardson, Elston/Ellis; HR, hazard ratio; CI, confidence interval; ER/PR, Estrogen/Progesterone receptor. All parameters were coded as 0 (negative) and 1 (positive) except as noted. Histologic type was coded as 1 (ductal), 2 (lobular ductal), 3 (ductal and lobular) and 4 (other).